T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer

NCT03530696 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Arizona

Collaborators